Council of Scientific and Industrial Research (CSIR) welcomed WHO’s move to resume hydroxychloroquine trials.
WHO on Thursday said HCQ will return to solidarity trial for potential treatment for Covid-19.
CSIR DG DR Shekhar Mande said WHO should have independently researched before halting HCQ trials.